Sentinel Lymph Node Biopsy (SLNB) may not be indicated for most melanomas <1mm thick

New guideline issued jointly by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SOS), and published online July 9 in the Journal of Clinical Oncology do not recommend SLNB for tumors that are less than 1mm thick, unless there is ulceration present or rapidly diving cancer cells present. The study reported that there is insufficient evidence supporting the need for SLNB in this subset of melanoma patients.


We want to know what you think. Leave a Reply.

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s